基于人群的评估:乳腺磁共振成像背景实质强化与未来原发性乳腺癌风险的关联
在乳腺癌监测联盟中评估4247名接受乳腺磁共振成像(MRI)的女性,中位随访2.8年,176例发生乳腺癌。背景实质强化(BPE)较轻微者,轻度、中度、明显的BPE均与乳腺癌风险显著升高相关,且独立于乳腺密度;作者认为BPE应考虑用于接受乳腺MRI女性的风险预测模型。
要点
- 在4247名女性中,176例发生乳腺癌(浸润性129例,导管原位癌47例),中位随访2.8年。
- 与轻微BPE相比,轻度BPE的HR为1.80(95%CI 1.12-2.87),中度BPE的HR为2.42(95%CI 1.51-3.86),明显BPE的HR为3.41(95%CI 2.05-5.66)。
- 合并轻度、中度、明显BPE与浸润性癌风险显著升高相关(HR 2.73,95%CI 1.66-4.49),与导管原位癌无显著关联(HR 1.48,95%CI 0.72-3.05)。
核心结论
- BPE与未来浸润性乳腺癌风险相关,且独立于乳腺密度。
- 作者认为,BPE应考虑用于接受乳腺MRI女性的风险预测模型。
研究设计与样本
- 基于乳腺癌监测联盟(Breast Cancer Surveillance Consortium)的人群研究,纳入2005年至2015年接受乳腺MRI的女性(含1例2000年检查),采用定性BPE评估(轻微、轻度、中度、明显)。
- 乳腺密度基于MRI前5年内进行的钼靶检查评估;乳腺癌患者若首次BPE评估早于首次诊断3个月以上则纳入。
- 采用Cox比例风险回归估计BPE相关乳腺癌风险;共纳入4247名女性,176例发生乳腺癌(浸润性129例,导管原位癌47例),中位随访2.8年。
主要发现
- 癌症女性中轻度、中度或明显BPE者比例高于无癌症女性(80% vs 66%)。
- 与轻微BPE相比,轻度BPE的HR为1.80(95%CI 1.12-2.87),中度BPE的HR为2.42(95%CI 1.51-3.86),明显BPE的HR为3.41(95%CI 2.05-5.66)。
- 与轻微BPE且乳腺几乎完全脂肪型或散在纤维腺体型密度的女性相比,轻度、中度或明显BPE者在几乎完全脂肪型或散在纤维腺体型密度中HR为2.30(95%CI 1.19-4.46),在 heterogeneous 或极度致密乳腺中HR为2.61(95%CI 1.44-4.72),交互作用无统计学显著(P=0.82)。
- 合并轻度、中度、明显BPE与浸润性癌风险显著升高相关(HR 2.73,95%CI 1.66-4.49),与导管原位癌无显著关联(HR 1.48,95%CI 0.72-3.05)。
临床怎么用
- 作者认为,BPE应考虑用于接受乳腺MRI女性的风险预测模型。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate comparative associations of breast magnetic resonance imaging (MRI) background parenchymal enhancement (BPE) and mammographic breast density with subsequent breast cancer risk. PATIENTS AND METHODS: We examined women undergoing breast MRI in the Breast Cancer Surveillance Consortium from 2005 to 2015 (with one exam in 2000) using qualitative BPE assessments of minimal, mild, moderate, or marked. Breast density was assessed on mammography performed within 5 years of MRI. Among women diagnosed with breast cancer, the first BPE assessment was included if it was more than 3 months before their first diagnosis. Breast cancer risk associated with BPE was estimated using Cox proportional hazards regression. RESULTS: Among 4,247 women, 176 developed breast cancer (invasive, n = 129; ductal carcinoma in situ,n = 47) over a median follow-up time of 2.8 years. More women with cancer had mild, moderate, or marked BPE than women without cancer (80% v 66%, respectively). Compared with minimal BPE, increasing BPE levels were associated with significantly increased cancer risk (mild: hazard ratio [HR], 1.80; 95% CI, 1.12 to 2.87; moderate: HR, 2.42; 95% CI, 1.51 to 3.86; and marked: HR, 3.41; 95% CI, 2.05 to 5.66). Compared with women with minimal BPE and almost entirely fatty or scattered fibroglandular breast density, women with mild, moderate, or marked BPE demonstrated elevated cancer risk if they had almost entirely fatty or scattered fibroglandular breast density (HR, 2.30; 95% CI, 1.19 to 4.46) or heterogeneous or extremely dense breasts (HR, 2.61; 95% CI, 1.44 to 4.72), with no significant interaction (P = .82). Combined mild, moderate, and marked BPE demonstrated significantly increased risk of invasive cancer (HR, 2.73; 95% CI, 1.66 to 4.49) but not ductal carcinoma in situ (HR, 1.48; 95% CI, 0.72 to 3.05). CONCLUSION: BPE is associated with future invasive breast cancer risk independent of breast density. BPE should be considered for risk prediction models for women undergoing breast MRI.
引用
- Arasu VA, Miglioretti DL, Sprague BL, et al. Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk. J Clin Oncol. 2019. PMID: 30625040. doi:10.1200/JCO.18.00378
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。